Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUIZARTINIB vs RALOXIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

QUIZARTINIB vs RALOXIFENE: Safety Overview

Metric QUIZARTINIB RALOXIFENE
Total FAERS Reports 357 4,185
Deaths Reported 61 34
Death Rate 17.1% 0.8%
Hospitalizations 121 346
Average Patient Age 54.0 yrs 67.7 yrs
% Female Patients 57.9% 99.7%
FDA Approval Date Jul 20, 2023 Apr 8, 2016
Manufacturer Daiichi Sankyo Inc. American Health Packaging
Route ORAL ORAL
Marketing Status Prescription Prescription